On the contrary, NDRs in prostate cancer-specific enhancers involved in enhancer–promoter loops are enriched for motifs for TFs such as FOXA1, GRHL2, ETS, and AR (Fig. 5b). This evidence concerns the gene FOXA1 and prostate carcinoma.